|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Restricted Stock Equivalent 11/3/2016 | $ 0 | 03/01/2019 | J | 992 | (2) | (2) | Common Stock | 992 | $ 0 | 3,470 (3) | D | ||||
Non-Qualified Stock Options 11/3/2016 | $ 74.7 | 03/01/2019 | J | 3,711 | (2) | (2) | Common Stock | 3,711 | $ 0 | 12,989 (4) | D | ||||
Performance Stock Equivalents 11/3/2016 | $ 0 | 03/01/2019 | J | 4,462 | (2) | (2) | Common Stock | 4,462 | $ 0 | 15,619 (5) | D | ||||
Restricted Stock Equivalent 11/13/2017 | $ 0 | 03/01/2019 | J | 4,981 | (2) | (2) | Common Stock | 4,981 | $ 0 | 6,225 (3) | D | ||||
Non-Qualified Stock Options 11/13/2017 | $ 58.9 | 03/01/2019 | J | 12,005 | (2) | (2) | Common Stock | 12,005 | $ 0 | 15,005 (4) | D | ||||
Performance Stock Equivalents 11/13/2017 | $ 0 | 03/01/2019 | J | 31,127 | (2) | (2) | Common Stock | 31,127 | $ 0 | 24,901 (6) | D | ||||
Restricted Stock Equivalents 11/15/2018 | $ 0 | 03/01/2019 | J | 23,180 | (2) | (2) | Common Stock | 23,180 | $ 0 | 0 | D | ||||
Non-Qualified Stock Options 11/15/2018 | $ 42.71 | 03/01/2019 | J | 50,887 | (2) | (2) | Common Stock | 50,887 | $ 0 | 0 | D | ||||
Performance Stock Equivalents 11/15/2018 | $ 0 | 03/01/2019 | J | 241,162 | (2) | (2) | Common Stock | 241,162 | $ 0 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
HATFIELD DAVID P C/O EDGEWELL PERSONAL CARE COMPANY 1350 TIMBERLAKE MANOR PARKWAY CHESTERFIELD, MO 63017 |
X |
Marisa Iasenza, Attorney-in-Fact | 03/04/2019 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hatfield's departure from the Company on March 1, 2019. These shares of Edgewell common stock will be delivered to Mr. Hatfield on September 3, 2019. |
(2) | Unvested award forfeited upon Mr. Hatfield's departure from the Company on March 1, 2019. |
(3) | These shares vested upon Mr. Hatfield's departure from the Company on March 1, 2019. These shares will be delivered to Mr. Hatfield on September 3, 2019. |
(4) | These options vested upon Mr. Hatfield's departure from the Company. He will have 5 years from his departure date to exercise them. |
(5) | These PSEs will vest and convert into shares of Edgewell common stock upon the release of earnings for fiscal year ending September 30, 2019 if specified performance criteria are met subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the adjusted earnings per share of the Company for its 2019 fiscal year. |
(6) | These PSEs will vest and convert into shares of Edgewell common stock upon the release of earnings for fiscal year ending September 30, 2020 if specified performance criteria are met subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs are the adjusted earnings per share of the Company for its 2020 fiscal year and the adjusted cumulative free cash flow of the Company for its 2020 fiscal year as a percentage of adjusted net sales of the Company for its 2020 fiscal year. |